$73.58
-0.87-1.17%
At close: -
$73.58
0.000.00%
After Hours: Feb 14, 4:10 PM EDT
AstraZeneca reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AstraZeneca using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-06 | $1.05 | $1.07 | -2.34 % |
Q3 | 2024-11-12 | $1.04 | $1.03 | 0.97 % |
Q2 | 2024-07-25 | $0.99 | $1.20 | -17.5 % |
Q1 | 2024-04-25 | $1.03 | $1.22 | -15.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-06 | $14.89B | $14.21B | 4.79 % |
Q3 | 2024-11-12 | $13.57B | $13.09B | 3.63 % |
Q2 | 2024-07-25 | $12.98B | $12.75B | 1.83 % |
Q1 | 2024-04-25 | $12.68B | $11.83B | 7.18 % |
AstraZeneca (AZN) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on February 6, 2025 for Q4.
The Actual EPS was $1.05, which missed the estimate of $1.07.
The Actual Revenue was $14.9B, which beat the estimate of $14.2B.
Browse earnings estimates, EPS, and revenue on all stocks.